The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis-Reference-Cited by-同舟云学术

The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis

Published:2019-12 Issue:6 Volume:19 Page:e731-e740
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Pavlović R.T.,Janković S.M.,Milovanović J.R.,Stefanović S.M.,Folić M.M.,Milovanović O.Z.,Mamillapalli C.,Milosavljević M.N.

Funder

Serbian Ministry of Education

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference53 articles.

1. Potent aromatase inhibitors and molecular mechanism of inhibitory action;Kang;Eur J Med Chem,2018

2. Meta-analysis of breast cancer outcome and toxicity in adjuvant trials of aromatase inhibitors in postmenopausal women;Aydiner;Breast,2013

3. Extending aromatase-inhibitor adjuvant therapy to 10 years;Goss;N Engl J Med,2016

4. Cardiovascular disease after aromatase inhibitor use;Haque;JAMA Oncol,2016

5. Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study;Blaes;Breast Cancer Res Treat,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients;Clinical and Translational Oncology;2024-08-29

2. Impact of vaginal estriol on serum hormone levels: a systematic review;Climacteric;2024-01-02

3. Vaginal laser therapy for urogenital symptoms in postmenopausal women and breast cancer survivors;Danish Journal of Obstetrics and Gynaecology;2023-11-15

4. A systematic review of randomised clinical trials – The safety of vaginal hormones and selective estrogen receptor modulators for the treatment of genitourinary menopausal symptoms in breast cancer survivors;Post Reproductive Health;2023-10-16

5. Estrogens and the risk of breast cancer: A narrative review of literature;Heliyon;2023-09